Search - tctmd.com

Displaying 1 - 20 of 95

Sort: Relevancy | Date

News Conference News TCT 2025

SAVE-PCI: Small-Bore Percutaneous VAD Matches IABP in High-risk PCI

Caitlin E. Cox

November 06, 2025

News Daily News

Disparities in MCS Use for STEMI-Related Shock Seen Across the US

Caitlin E. Cox

October 21, 2025

News Daily News

Lactate Clearance May Act as ‘Early Warning Sign’ in Cardiogenic Shock

L.A. McKeown

September 25, 2025

News Conference News ESC 2025

DanGer Shock: Impella Tied to Better Survival Even 10 Years Later

Caitlin E. Cox

September 08, 2025

Presentation TCT 2024

TCT 283: Clinical Outcomes of Patients Receiving IABP From the Cardiogenic Shock Working Group: A Comparison of Heart Failure and Myocardial Infarction Related Cardiogenic Shock

Presenter: Arthur Garan

October 29, 2024

Presentation TCT 2024

TCT 1094: Calming the VF Storm With Stellate Ganglion Block and PCI Bifurcation LAD-DG via Tortuous Radial Artery in Inferior Wall STEMI S/P VA ECMO, IABP, IJ Pacemaker

Presenter: Wittawat Wattanasiriporn

October 28, 2024

Presentation TCT 2024

TCT 581: Microaxial Circulatory Flow Pump Supported-PCI Is Associated With Reduced Major Adverse Kidney Events Compared to IABP-Supported PCI in Real-World Settings

Presenter: Amin Polzin

October 28, 2024

News Daily News

Everyone’s Glum About RECOVER IV: Where Shock Care Heads Next Is Unclear

Caitlin E. Cox

July 03, 2024

News Daily News

FDA Expresses Continuing Concerns About Getinge/Maquet CV Devices

Todd Neale

May 08, 2024

News Features

After DanGer Shock’s Win in AMICS for Impella: What’s Next?

Caitlin E. Cox

May 02, 2024

News Conference News ESC 2023

Routine ECMO in AMICS Patients Not Protective: ECLS-SHOCK

Caitlin E. Cox

August 26, 2023

News Daily News

Cardiosave IABPs—Yet Again—the Subject of a Class I Recall: FDA

Caitlin E. Cox

August 17, 2023

News Daily News

Cardiosave IABPs Recalled Again, This Time Due to Potential Electrical Problems: FDA

Michael O'Riordan

August 10, 2023

News Daily News

Medicare Data on AMICS Too Muddied for Firm Conclusions on Impella

Caitlin E. Cox

June 21, 2023

News Daily News

Another Recall Warns of Unheralded Shutdowns With Cardiosave IABPs

Shelley Wood

March 31, 2023

News Daily News

Second Recall in Less Than 2 Months for Cardiosave IABPs

L.A. McKeown

March 17, 2023

News Conference News STS 2023

Risk Stratify to Avoid Postcardiotomy Shock Following CV Surgery

Yael L. Maxwell

January 23, 2023

News Daily News

Cardiogenic Shock Outcomes Markedly Worse in De Novo HF Patients

Caitlin E. Cox

December 09, 2022

News Daily News

US Claims Data Point to Better Survival With Impella vs IABP in High-Risk PCI

Caitlin E. Cox

October 20, 2022

Presentation TCT 2022

When and How to Choose IABP, Impella, TandemHeart, or ECMO in CS

Presenter: Koji Takeda

September 19, 2022

Advertisement

SAVE-PCI: Small-Bore Percutaneous VAD Matches IABP in High-risk PCI

Disparities in MCS Use for STEMI-Related Shock Seen Across the US

Lactate Clearance May Act as ‘Early Warning Sign’ in Cardiogenic Shock

DanGer Shock: Impella Tied to Better Survival Even 10 Years Later

TCT 283: Clinical Outcomes of Patients Receiving IABP From the Cardiogenic Shock Working Group: A Comparison of Heart Failure and Myocardial Infarction Related Cardiogenic Shock

TCT 1094: Calming the VF Storm With Stellate Ganglion Block and PCI Bifurcation LAD-DG via Tortuous Radial Artery in Inferior Wall STEMI S/P VA ECMO, IABP, IJ Pacemaker

TCT 581: Microaxial Circulatory Flow Pump Supported-PCI Is Associated With Reduced Major Adverse Kidney Events Compared to IABP-Supported PCI in Real-World Settings

Everyone’s Glum About RECOVER IV: Where Shock Care Heads Next Is Unclear

FDA Expresses Continuing Concerns About Getinge/Maquet CV Devices

After DanGer Shock’s Win in AMICS for Impella: What’s Next?

Routine ECMO in AMICS Patients Not Protective: ECLS-SHOCK

Cardiosave IABPs—Yet Again—the Subject of a Class I Recall: FDA

Cardiosave IABPs Recalled Again, This Time Due to Potential Electrical Problems: FDA

Medicare Data on AMICS Too Muddied for Firm Conclusions on Impella

Another Recall Warns of Unheralded Shutdowns With Cardiosave IABPs

Second Recall in Less Than 2 Months for Cardiosave IABPs

Risk Stratify to Avoid Postcardiotomy Shock Following CV Surgery

Cardiogenic Shock Outcomes Markedly Worse in De Novo HF Patients

US Claims Data Point to Better Survival With Impella vs IABP in High-Risk PCI

When and How to Choose IABP, Impella, TandemHeart, or ECMO in CS

Advertisement

Advertisement

Sign In

Forgot Your Password?

Search TCTMD

CME TITLE

Sign up for our newsletter

Search TCTMD

Submit an Event

Become a PREMIUM MEMBER or LOG IN to view exclusive content

REGISTER for free or LOG IN to view this content